» Articles » PMID: 32552892

A Comparative Study of Long Interspersed Element-1 Protein Immunoreactivity in Cutaneous Malignancies

Overview
Journal BMC Cancer
Publisher Biomed Central
Specialty Oncology
Date 2020 Jun 20
PMID 32552892
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Skin cancer is the most common cancer worldwide and commonly classified into malignant melanoma (MM) and Nonmelanoma skin cancers (NMSCs), which mainly include basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). The extent to which Long Interspersed Element-1 (LINE-1, L1) ORF1p is expressed in cutaneous malignancies remains to be evaluated. This study aimed to assess LINE-1 ORF1p immunoreactivity in various skin cancer subtypes.

Method: The expression level of LINE-1 ORF1p was evaluated in 95 skin cancer specimens comprising 36 (37.9%) BCC, 28 (29.5%) SCC, and 31 (32.6%) melanoma using the tissue microarray (TMA) technique. Then the association between expression of LINE-1 encoded protein and clinicopathological parameters was analyzed.

Results: We showed that LINE-1 ORF1p expression level was substantially higher in BCC and SCC patients compared with melanoma samples (p < 0.001). BCC cases had a higher LINE-1 histochemical score (H-score) compared with SCC cases (p = 0.004). In SCC samples, a lower level of LINE-1 ORF1p expression was associated with age younger than the mean (p = 0.041). At the same time, no significant correlation was found between LINE-1 ORF1p expression and other clinicopathological parameters (all p > 0.05).

Conclusions: According to our observation, LINE-1 ORF1p immunoreactivity in various skin tumor subtypes extends previous studies of LINE-1 expression in different cancers. LINE-1ORF1p overexpression in NMSCs compared with MM can be considered with caution as a tumor-specific antigen for NMSCs.

Citing Articles

LINE-1 methylation status and survival outcomes in colorectal cancer patients: A systematic review and meta-analysis.

Bagheri A, Jafari-Koshki T, Alizadeh L, Raeisi M, Moaddab Y, Karimi A Heliyon. 2025; 11(3):e42410.

PMID: 39995903 PMC: 11849065. DOI: 10.1016/j.heliyon.2025.e42410.


Clinical implications of Alu-based cell-free DNA and serum onco-piRNA monitoring in colorectal cancer management.

Taghizadeh-Teymorloei M, Jafarlou V, Matin S, Raeisi M, Roosta Y, Mansouri-Derakhshani S Clin Transl Oncol. 2025; .

PMID: 39969763 DOI: 10.1007/s12094-025-03863-8.


Scientific Research Directions on the Histopathology and Immunohistochemistry of the Cutaneous Squamous Cell Carcinoma: A Scientometric Study.

Cocuz I, Cocuz M, Repanovici A, Sabau A, Niculescu R, Tinca A Medicina (Kaunas). 2022; 58(10).

PMID: 36295609 PMC: 9611311. DOI: 10.3390/medicina58101449.


Significant co-expression of putative cancer stem cell markers, EpCAM and CD166, correlates with tumor stage and invasive behavior in colorectal cancer.

Kalantari E, Taheri T, Fata S, Abolhasani M, Mehrazma M, Madjd Z World J Surg Oncol. 2022; 20(1):15.

PMID: 35016698 PMC: 8751119. DOI: 10.1186/s12957-021-02469-y.


Lamivudine improves cognitive decline in SAMP8 mice: Integrating in vivo pharmacological evaluation and network pharmacology.

Li M, Zhao J, Tang Q, Zhang Q, Wang Y, Zhang J J Cell Mol Med. 2021; 25(17):8490-8503.

PMID: 34374199 PMC: 8419189. DOI: 10.1111/jcmm.16811.

References
1.
Harris C, Normart R, Yang Q, Stevenson E, Haffty B, Ganesan S . Association of nuclear localization of a long interspersed nuclear element-1 protein in breast tumors with poor prognostic outcomes. Genes Cancer. 2010; 1(2):115-24. PMC: 2952938. DOI: 10.1177/1947601909360812. View

2.
Ardeljan D, Taylor M, Ting D, Burns K . The Human Long Interspersed Element-1 Retrotransposon: An Emerging Biomarker of Neoplasia. Clin Chem. 2017; 63(4):816-822. PMC: 6177209. DOI: 10.1373/clinchem.2016.257444. View

3.
Rigel D, Russak J, Friedman R . The evolution of melanoma diagnosis: 25 years beyond the ABCDs. CA Cancer J Clin. 2010; 60(5):301-16. DOI: 10.3322/caac.20074. View

4.
Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S . Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998; 4(7):844-7. DOI: 10.1038/nm0798-844. View

5.
Del Re B, Marcantonio P, Gavoci E, Bersani F, Giorgi G . Assessing LINE-1 retrotransposition activity in neuroblastoma cells exposed to extremely low-frequency pulsed magnetic fields. Mutat Res. 2012; 749(1-2):76-81. DOI: 10.1016/j.mrgentox.2012.07.004. View